Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious disease...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
